Sandy Shah, MD

Dr. Radhika Shah is a board-certified medical oncologist with extensive expertise in clinical research and patient care. As VP of Oncology- Medical Affairs, at Premier Research, she provides strategic medical oversight to global oncology clinical trials, ensuring scientific integrity and patient safety throughout the research process.

She previously served as a Medical Monitor at a large CRO, where she played a key role in designing and overseeing clinical trials to advance safer and more effective cancer treatments. Prior to that, she was an Assistant Professor at Duke University, Assistant Chief, and Fellowship Director at the Durham Veterans Affairs, where she trained future oncologists. With over a decade of clinical experience, Dr. Shah has managed patients with both solid tumors and hematologic malignancies, including the management of breast and gynecologic malignancies.

Dr. Shah has significant expertise in the management of global Phase I–IV clinical trials. She is committed to enhancing patient safety and improving trial accessibility, particularly for women’s cancer care.

She maintains an active medical license in North Carolina and is a dedicated advocate for advancing oncology research. Dr. Shah is an engaged member of the American Society of Clinical Oncology (ASCO) and the American Society of Hematology (ASH). She continues to contribute to the field through poster presentations, publications, and thought leadership in clinical trial innovation.